Related Experiment Video
Updated: Oct 25, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesionand spreading
D H Gutmann1, L Sherman, L Seftor
1The Department of Neurology, Washington University School of Medicine, St Louis, MO 63110, USA. gutmannd@neuro.wustl.edu
Abstract:
The neurofibromatosis 2 ( NF2 ) gene product, merlin, is a tumor suppressor protein mutated in schwanno-mas and several other tumors. Merlin, which shares significant homology with the actin-associated proteins ezrin, radixin and moesin (ERM proteins), inhibits cell growth when overexpressed in cell lines. The similarities between merlin and ERM proteins suggest that merlin's growth-regulatory capabilities may be due to alterations in cytoskeletal function. We examined this possibility in rat schwannoma cell lines overexpressing wild-type merlin isoforms and mutant merlin proteins. We found that overexpression of wild-type merlin resulted in transient alterations in F-actin organization, cell spreading and cell attachment. Merlin overexpression also impaired cell motility as measured in an in vitro motility assay. These effects were only observed in cells overexpressing a merlin isoform capable of inhibiting cell growth and not with mutant merlin molecules (NF2 patient mutations) or a merlin splice variant (isoform II) lacking growth-inhibitory activity. These data indicate that merlin may function to maintain normal cytoskeletal organization, and suggest that merlin's influence on cell growth depends on specific cytoskeletal rearrangements.
Insights
The neurofibromatosis 2 (NF2) gene product, merlin, impacts cell growth by altering cytoskeletal function. This tumor suppressor influences cell shape, attachment, and movement, linking its growth inhibition to cytoskeletal rearrangements.
Area of Science:
- Cell Biology
- Molecular Biology
- Oncology
Background:
- Neurofibromatosis 2 (NF2) gene product, merlin, is a tumor suppressor protein. Merlin mutations are found in schwannomas and other tumors.
- Merlin shares homology with ezrin, radixin, and moesin (ERM) proteins, suggesting a role in cytoskeletal regulation.
Purpose of the Study:
- To investigate whether merlin's growth-regulatory capabilities are mediated by alterations in cytoskeletal function.
- To examine the effects of wild-type and mutant merlin isoforms on cytoskeletal organization and cell behavior.
Main Methods:
- Overexpression of wild-type merlin isoforms and mutant merlin proteins in rat schwannoma cell lines.
- Analysis of F-actin organization, cell spreading, cell attachment, and cell motility.
- Comparison of effects between growth-inhibitory merlin isoforms and non-inhibitory variants or mutants.
Main Results:
- Overexpression of wild-type merlin caused transient changes in F-actin organization, cell spreading, and attachment.
- Merlin overexpression impaired cell motility in vitro.
- These cytoskeletal effects were dependent on merlin's growth-inhibitory activity, as mutant or non-inhibitory isoforms did not produce similar results.
Conclusions:
- Merlin functions in maintaining normal cytoskeletal organization.
- Merlin's influence on cell growth is linked to specific cytoskeletal rearrangements.
- These findings suggest a mechanism for merlin's tumor suppressor activity involving cytoskeletal regulation.
Related Concept Videos
Abnormal Proliferation
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Cell Migration
Cell Migration
Microtubules in Cell Motility
Cell Motility through Blebbing
Blebbing Through the Matrix
In multicellular...
